ARCHIVES

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

AACI Developing Suggestions Or New Cancer Control Grant Guidelines

July 20, 1979

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994

NCI Research Project Grant Funding To Exceed $1 Billion In Fiscal 1997

March 14, 1997

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

NCCS Networker Volume 5 Issue 2, Spring 1991

April 13, 1991

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005